UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pharmacokinetics and elimination of moxifloxacin after oral and intravenous administration in man

Journal of antimicrobial chemotherapy, 1999-05, Vol.43 Suppl B (suppl_2), p.83-90

1999

Volltextzugriff (PDF)

Pharmacokinetics, Safety, and Tolerability of Ascending Single Doses of Moxifloxacin, a New 8-Methoxy Quinolone, Administered to Healthy Subjects

Antimicrobial Agents and Chemotherapy, 1998-08, Vol.42 (8), p.2060-2065

1998

Volltextzugriff (PDF)

Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: a comparison in humans and other mammalian species

Journal of antimicrobial chemotherapy, 1999-05, Vol.43 Suppl B (suppl_2), p.69-76

1999

Volltextzugriff (PDF)

Profile of Moxifloxacin Drug Interactions

Clinical infectious diseases, 2001-03, Vol.32 (Supplement-1), p.S47-S50

2001

Volltextzugriff (PDF)

Safety and pharmacokinetics of a recombinant factor VIII with pegylated liposomes in severe hemophilia A

Journal of thrombosis and haemostasis, 2008-02, Vol.6 (2), p.277-283

2008

Volltextzugriff (PDF)

Pharmacokinetics and peritoneal penetration of moxifloxacin in peritonitis

Journal of antimicrobial chemotherapy, 2006-09, Vol.58 (3), p.693-696

2006

Volltextzugriff (PDF)

Influence of activated charcoal on the pharmacokinetics of moxifloxacin following intravenous and oral administration of a 400 mg single dose to healthy males

British journal of clinical pharmacology, 2005-05, Vol.59 (5), p.536-541

2005

Volltextzugriff (PDF)

Stability, efficacy, and safety of continuously infused sucrose-formulated recombinant factor VIII (rFVIII-FS) during surgery in patients with severe haemophilia

Haemophilia : the official journal of the World Federation of Hemophilia, 2009-05, Vol.15 (3), p.676-685

2009

Volltextzugriff (PDF)

Pharmacokinetics of moxifloxacin, a novel 8‐methoxy‐quinolone, in patients with renal dysfunction

British journal of clinical pharmacology, 2002-03, Vol.53 (3), p.232-237

2002

Volltextzugriff (PDF)

Determination of the Concentration of Ciprofloxacin in Prostate Tissue Following Administration of a Single, 1000 mg, Extended-Release Dose

Journal of chemotherapy (Florence), 2008-04, Vol.20 (2), p.213-218

2008

Volltextzugriff (PDF)

A40 CYSTIC FIBROSIS AND NON-CYSTIC FIBROSIS BRONCHIECTASIS: Population Pharmacokinetic (pk) Analysis In Non-Cystic Fibrosis Bronchiectasis (ncfb) Patients Under 32.5 Mg Bid Intermittent Therapy With Ciprofloxacin Dry Powder For Inhalation (dpi)

American journal of respiratory and critical care medicine, 2017-01, Vol.195

2017

Volltextzugriff (PDF)

The integrated use of pharmacokinetic and pharmacodynamic models for the definition of breakpoints

Infection, 2005-12, Vol.33 Suppl 2 (S2), p.29-35

2005

Volltextzugriff (PDF)

Absorption and Bioavailability of Moxifloxacin

Drugs (New York, N.Y.), 1999, Vol.58 (Supplement 2), p.227-228

Stass, H

1999

Volltextzugriff (PDF)

Metabolism and Excretion of Moxifloxacin

Drugs (New York, N.Y.), 1999, Vol.58 (Supplement 2), p.231-232

Stass, H

1999

Volltextzugriff (PDF)

Distribution and Tissue Penetration of Moxifloxacin

Drugs (New York, N.Y.), 1999, Vol.58 (Supplement 2), p.229-230

Stass, H

1999

Volltextzugriff (PDF)

Pharmacokinetic/pharmacodynamic (PK/PD) evaluation of a once-daily treatment using ciprofloxacin in an extended-release dosage form

Infection, 2005-12, Vol.33 Suppl 2 (S2), p.22-28

2005

Volltextzugriff (PDF)

Determination of minimal sampling time points for reliable pharmacokinetic evaluation of recombinant factor VIII - an exploratory population pharmacokinetic analysis in paediatric patients suffering from severe haemophilia

Haemophilia : the official journal of the World Federation of Hemophilia, 2006-11, Vol.12 (s4), p.50-55

STASS, H.

2006

Volltextzugriff (PDF)

The influence of continuous venovenous haemodialysis on the pharmacokinetics of multiple oral moxifloxacin administration to patients with severe renal dysfunction

British journal of clinical pharmacology, 2007-12, Vol.64 (6), p.745-749

2007

Volltextzugriff (PDF)

Pharmacodynamics of moxifloxacin and levofloxacin simulating human serum and lung concentrations

Infection, 2005-12, Vol.33 Suppl 2 (S2), p.15-21

2005

Volltextzugriff (PDF)

A40 CYSTIC FIBROSIS AND NON-CYSTIC FIBROSIS BRONCHIECTASIS: Characteristics Of The T-326 Inhaler Important For Effective Inhalation Treatment With Ciprofloxacin Dry Powder For Inhalation In Patients With Non-Cystic Fibrosis Bronchiectasis

American journal of respiratory and critical care medicine, 2017-01, Vol.195

2017

Volltextzugriff (PDF)

P2069 Relationship of plasma concentration and changes in the QTc interval in hospitalised patients receiving intravenous moxifioxacin for the treatment of community-acquired pneumonia

International journal of antimicrobial agents, 2007, Vol.29, p.S597-S597

2007

Volltextzugriff (PDF)

Safety and pharmacokinetics of a recombinant factor VIII with pegylated liposomes in severe hemophilia A

Journal of thrombosis and haemostasis, 2008-02, Vol.6 (2), p.277-283

2008

Volltextzugriff (PDF)

A prospective, multicentre study of moxifloxacin concentrations in the sinus mucosa tissue of patients undergoing elective surgery of the sinus

Journal of antimicrobial chemotherapy, 2002-05, Vol.49 (5), p.821-826

2002

Volltextzugriff (PDF)

Ciprofloxacin pharmacokinetic profiles in paediatric sepsis: how much ciprofloxacin is enough?

Intensive care medicine, 2002-04, Vol.28 (4), p.493-500

2002

Volltextzugriff (PDF)

Pharmacokinetics of ciprofloxacin PulmoSphere® inhalational powder

Journal of cystic fibrosis, 2008-06, Vol.7, p.S26-S26

2008

Volltextzugriff (PDF)

1 – 25 von 283

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(260)
Mit Volltextzugriff
(248)

Publikationsform

Sprache

Englisch
(279)
Deutsch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(196)
Humans
(136)
Life Sciences & Biomedicine
(129)
Male
(84)
Biological And Medical Sciences
(75)
Medical Sciences
(72)
Adult
(71)
Physical Sciences
(69)
Physics
(66)
Physics, Condensed Matter
(66)
Female
(63)
Materials Science
(50)
Technology
(49)
Materials Science, Coatings & Films
(46)
Physics, Applied
(46)
Middle Aged
(40)
Pharmacology. Drug Treatments
(37)
Hematology
(35)
Fluoroquinolones
(30)
Hematologic And Hematopoietic Diseases
(30)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pharmacokinetics and elimination of moxifloxacin after oral and intravenous administration in man

Pharmacokinetics, Safety, and Tolerability of Ascending Single Doses of Moxifloxacin, a New 8-Methoxy Quinolone, Administered to Healthy Subjects

Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: a comparison in humans and other mammalian species

Profile of Moxifloxacin Drug Interactions

Safety and pharmacokinetics of a recombinant factor VIII with pegylated liposomes in severe hemophilia A

Pharmacokinetics and peritoneal penetration of moxifloxacin in peritonitis

Influence of activated charcoal on the pharmacokinetics of moxifloxacin following intravenous and oral administration of a 400 mg single dose to healthy males

Stability, efficacy, and safety of continuously infused sucrose-formulated recombinant factor VIII (rFVIII-FS) during surgery in patients with severe haemophilia

Pharmacokinetics of moxifloxacin, a novel 8‐methoxy‐quinolone, in patients with renal dysfunction

Determination of the Concentration of Ciprofloxacin in Prostate Tissue Following Administration of a Single, 1000 mg, Extended-Release Dose

A40 CYSTIC FIBROSIS AND NON-CYSTIC FIBROSIS BRONCHIECTASIS: Population Pharmacokinetic (pk) Analysis In Non-Cystic Fibrosis Bronchiectasis (ncfb) Patients Under 32.5 Mg Bid Intermittent Therapy With Ciprofloxacin Dry Powder For Inhalation (dpi)

The integrated use of pharmacokinetic and pharmacodynamic models for the definition of breakpoints

Absorption and Bioavailability of Moxifloxacin

Metabolism and Excretion of Moxifloxacin

Distribution and Tissue Penetration of Moxifloxacin

Pharmacokinetic/pharmacodynamic (PK/PD) evaluation of a once-daily treatment using ciprofloxacin in an extended-release dosage form

Determination of minimal sampling time points for reliable pharmacokinetic evaluation of recombinant factor VIII - an exploratory population pharmacokinetic analysis in paediatric patients suffering from severe haemophilia

The influence of continuous venovenous haemodialysis on the pharmacokinetics of multiple oral moxifloxacin administration to patients with severe renal dysfunction

Pharmacodynamics of moxifloxacin and levofloxacin simulating human serum and lung concentrations

A40 CYSTIC FIBROSIS AND NON-CYSTIC FIBROSIS BRONCHIECTASIS: Characteristics Of The T-326 Inhaler Important For Effective Inhalation Treatment With Ciprofloxacin Dry Powder For Inhalation In Patients With Non-Cystic Fibrosis Bronchiectasis

P2069 Relationship of plasma concentration and changes in the QTc interval in hospitalised patients receiving intravenous moxifioxacin for the treatment of community-acquired pneumonia

Safety and pharmacokinetics of a recombinant factor VIII with pegylated liposomes in severe hemophilia A

A prospective, multicentre study of moxifloxacin concentrations in the sinus mucosa tissue of patients undergoing elective surgery of the sinus

Ciprofloxacin pharmacokinetic profiles in paediatric sepsis: how much ciprofloxacin is enough?

Pharmacokinetics of ciprofloxacin PulmoSphere® inhalational powder

Suchergebnisse filtern